NASDAQ:CSII - Cardiovascular Systems Stock Price, Price Target & More

$22.52 -0.17 (-0.75 %)
(As of 04/20/2018 04:00 PM ET)
Previous Close$22.52
Today's Range$22.31 - $22.77
52-Week Range$20.58 - $33.11
Volume78,387 shs
Average Volume185,025 shs
Market Capitalization$753.72 million
P/E Ratio750.67
Dividend YieldN/A
Beta2.15

About Cardiovascular Systems (NASDAQ:CSII)

Cardiovascular Systems logoCardiovascular Systems, Inc., a medical technology company, develops, manufactures, and markets devices to treat vascular diseases in the United States. The company offers peripheral arterial disease products, including Diamondback 360 Peripheral Orbital Atherectomy System (OAS), Diamondback 360 60cm Peripheral OAS, Diamondback 360 4 French 1.25 Peripheral OAS, Diamondback 360 1.50 Peripheral OAS, Diamondback 360 2.00 Peripheral OAS, and Stealth 360 Peripheral OAS, which are catheter-based platforms for treating a range of plaque types in leg arteries above and below the knee, including calcified plaque, as well as address various limitations associated with surgical, catheter, and pharmacological treatment alternatives. It also provides Diamondback 360 Coronary OAS, an atherectomy device for the treatment of calcified coronary arteries. The company sells its products directly to hospitals or office-based labs. Cardiovascular Systems, Inc. was founded in 1989 and is headquartered in St. Paul, Minnesota.

Receive CSII News and Ratings via Email

Sign-up to receive the latest news and ratings for CSII and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
SymbolNASDAQ:CSII
CUSIP14161910
Phone651-259-1600

Debt

Debt-to-Equity Ratio0.17%
Current Ratio4.65%
Quick Ratio4.13%

Price-To-Earnings

Trailing P/E Ratio750.67
Forward P/E Ratio-321.71
P/E GrowthN/A

Sales & Book Value

Annual Sales$204.91 million
Price / Sales3.65
Cash Flow$0.1550 per share
Price / Cash145.28
Book Value$3.62 per share
Price / Book6.22

Profitability

EPS (Most Recent Fiscal Year)$0.03
Net Income$-1,790,000.00
Net Margins-1.62%
Return on Equity-0.50%
Return on Assets-0.31%

Miscellaneous

Employees579
Outstanding Shares33,220,000

How to Become a New Pot Stock Millionaire

Cardiovascular Systems (NASDAQ:CSII) Frequently Asked Questions

What is Cardiovascular Systems' stock symbol?

Cardiovascular Systems trades on the NASDAQ under the ticker symbol "CSII."

How were Cardiovascular Systems' earnings last quarter?

Cardiovascular Systems, Inc. (NASDAQ:CSII) released its earnings results on Wednesday, February, 7th. The medical device company reported ($0.01) EPS for the quarter, beating the consensus estimate of ($0.04) by $0.03. The medical device company earned $52.63 million during the quarter, compared to analyst estimates of $53.39 million. Cardiovascular Systems had a negative net margin of 1.62% and a negative return on equity of 0.50%. The business's quarterly revenue was up 5.2% on a year-over-year basis. During the same period in the prior year, the business earned $0.03 earnings per share. View Cardiovascular Systems' Earnings History.

When is Cardiovascular Systems' next earnings date?

Cardiovascular Systems is scheduled to release their next quarterly earnings announcement on Wednesday, May, 2nd 2018. View Earnings Estimates for Cardiovascular Systems.

What guidance has Cardiovascular Systems issued on next quarter's earnings?

Cardiovascular Systems issued an update on its third quarter earnings guidance on Wednesday, February, 7th. The company provided EPS guidance of ($0.03)-$0.00 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.03. The company issued revenue guidance of $55-56.5 million, compared to the consensus revenue estimate of $58.69 million.

What price target have analysts set for CSII?

6 Wall Street analysts have issued 1-year price objectives for Cardiovascular Systems' stock. Their forecasts range from $23.00 to $30.00. On average, they expect Cardiovascular Systems' share price to reach $26.50 in the next twelve months. View Analyst Ratings for Cardiovascular Systems.

What are Wall Street analysts saying about Cardiovascular Systems stock?

Here are some recent quotes from research analysts about Cardiovascular Systems stock:
  • 1. According to Zacks Investment Research, "Cardiovascular Systems exited second-quarter fiscal 2018 on a solid note with year-over-year increase in revenues at both CAD and PAD businesses. Also, the expansion is gross margin was impressive. Moreover, the company is putting efforts in product innovation through R&D investments. The market is also looking forward to the recently-launched coronary device in Japan, reflecting the company’s focus on international expansion. On the flip side, Cardiovascular Systems faces cutthroat competition in the niche space. Coming to profitability, Cardio Vascular incurred net loss in the recently-reported second quarter. In fact, the company has a long history of net losses since inception. Also, the lowered revenue guidance for fiscal 2018 is discouraging. Over the past year, Cardiovascular Systems has been trading below the broader industry." (2/12/2018)
  • 2. Needham & Company LLC analysts commented, "CSII’s F1Q18 revenue and EPS beat consensus though we note that CSII had announced on 9/18/17 that it expected to miss its original guidance due to the hurricanes. F2Q18 revenue and EPS guidance were below consensus although management maintained its FY18 revenue guidance since it expects recent sales force changes to reaccelerate its coronary sales. While CSII faces its most difficult comp in F2Q18, we expect growth to accelerate in CY18 as comps begin to ease, the sales force changes improve coronary sales, CSII launches its coronary product in Japan and support products (such as guide wires) in the US." (10/26/2017)

Who are some of Cardiovascular Systems' key competitors?

Who are Cardiovascular Systems' key executives?

Cardiovascular Systems' management team includes the folowing people:
  • Mr. Scott Raymond Ward MS, B.Sc., Chairman, Chief Exec. Officer and Pres (Age 58)
  • Mr. Laurence L. Betterley, VP of Admin. (Age 64)
  • Ms. Laura J. Gillund, Chief Talent Officer (Age 57)
  • Mr. Jeffrey S. Points, Chief Financial Officer
  • Ms. Rhonda J. Robb, Chief Operating Officer

Has Cardiovascular Systems been receiving favorable news coverage?

Media headlines about CSII stock have been trending somewhat positive this week, according to Accern Sentiment Analysis. The research group rates the sentiment of press coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Cardiovascular Systems earned a news sentiment score of 0.19 on Accern's scale. They also gave news stories about the medical device company an impact score of 46.43 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the next few days.

Who are Cardiovascular Systems' major shareholders?

Cardiovascular Systems' stock is owned by a number of of retail and institutional investors. Top institutional investors include CHAMPLAIN INVESTMENT PARTNERS, LLC (6.81%). Company insiders that own Cardiovascular Systems stock include Alexander Rosenstein, Camber Capital Management Llc, Edward M Brown, Kevin J Kenny, Laura Gillund, Laurence L Betterley, Paul A Koehn and Scott R Ward. View Institutional Ownership Trends for Cardiovascular Systems.

How do I buy shares of Cardiovascular Systems?

Shares of CSII can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Cardiovascular Systems' stock price today?

One share of CSII stock can currently be purchased for approximately $22.52.

How big of a company is Cardiovascular Systems?

Cardiovascular Systems has a market capitalization of $753.72 million and generates $204.91 million in revenue each year. The medical device company earns $-1,790,000.00 in net income (profit) each year or $0.03 on an earnings per share basis. Cardiovascular Systems employs 579 workers across the globe.

How can I contact Cardiovascular Systems?

Cardiovascular Systems' mailing address is 1225 OLD HWY 8 NW, ST. PAUL MN, 55112. The medical device company can be reached via phone at 651-259-1600 or via email at [email protected]


MarketBeat Community Rating for Cardiovascular Systems (CSII)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  268 (Vote Outperform)
Underperform Votes:  188 (Vote Underperform)
Total Votes:  456
MarketBeat's community ratings are surveys of what our community members think about Cardiovascular Systems and other stocks. Vote "Outperform" if you believe CSII will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CSII will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Cardiovascular Systems (NASDAQ:CSII) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
6 Wall Street analysts have issued ratings and price targets for Cardiovascular Systems in the last 12 months. Their average twelve-month price target is $26.50, suggesting that the stock has a possible upside of 17.67%. The high price target for CSII is $30.00 and the low price target for CSII is $23.00. There are currently 1 sell rating, 4 hold ratings and 1 buy rating for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldBuy
Consensus Rating Score: 2.002.002.002.57
Ratings Breakdown: 1 Sell Rating(s)
4 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
4 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
4 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
2 Hold Rating(s)
3 Buy Rating(s)
1 Strong Buy Rating(s)
Consensus Price Target: $26.50$26.50$31.50$34.25
Price Target Upside: 17.67% upside13.98% upside31.69% upside20.22% upside

Cardiovascular Systems (NASDAQ:CSII) Consensus Price Target History

Price Target History for Cardiovascular Systems (NASDAQ:CSII)

Cardiovascular Systems (NASDAQ:CSII) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/8/2018Leerink SwannLower Price TargetOutperform -> Outperform$31.00 -> $30.00HighView Rating Details
12/21/2017William BlairReiterated RatingMarket PerformLowView Rating Details
12/15/2017Needham & Company LLCDowngradeBuy -> Hold$33.11 -> $23.00HighView Rating Details
12/4/2017Raymond JamesReiterated RatingHoldLowView Rating Details
9/21/2017CitigroupInitiated CoverageMarket PerformLowView Rating Details
6/21/2017Bank of AmericaDowngradeNeutral -> UnderperformLowView Rating Details
1/30/2017Lake Street CapitalInitiated CoverageBuy$40.00N/AView Rating Details
10/27/2016Feltl & Co.UpgradeBuy -> Strong-Buy$30.00N/AView Rating Details
10/7/2016JMP SecuritiesInitiated CoverageOutperform$35.00N/AView Rating Details
(Data available from 4/21/2016 forward)

Earnings

Cardiovascular Systems (NASDAQ:CSII) Earnings History and Estimates Chart

Earnings by Quarter for Cardiovascular Systems (NASDAQ:CSII)

Cardiovascular Systems (NASDAQ:CSII) Earnings Estimates

2018 EPS Consensus Estimate: $0.02
2019 EPS Consensus Estimate: $0.07
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20184($0.08)$0.00($0.02)
Q2 20184($0.05)$0.03$0.01
Q3 20184($0.03)$0.04$0.00
Q4 20184$0.01$0.08$0.04
Q1 20193($0.06)$0.03($0.03)
Q2 20193($0.06)$0.06($0.01)
Q3 20193($0.02)$0.07$0.03
Q4 20193$0.05$0.12$0.08

Cardiovascular Systems (NASDAQ CSII) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/1/2018$0.04N/AView Earnings Details
2/7/2018Q2 2018($0.04)($0.01)$53.39 million$52.63 millionViewListenView Earnings Details
10/25/2017Q1 2018($0.08)($0.06)$51.00 million$49.70 millionViewN/AView Earnings Details
8/2/2017Q4 2017($0.05)$0.02$51.98 million$52.90 millionViewListenView Earnings Details
5/3/2017Q3 2017($0.05)($0.05)$51.13 million$52.10 millionViewListenView Earnings Details
1/25/2017Q217($0.06)$0.03$49.72 million$50.00 millionViewN/AView Earnings Details
10/26/2016Q117($0.18)($0.06)$205.50 million$49.80 millionViewListenView Earnings Details
8/3/2016Q416($0.20)($0.15)$46.01 million$48.50 millionViewN/AView Earnings Details
5/4/2016Q316($0.54)($0.31)$42.13 million$44.50 millionViewN/AView Earnings Details
1/21/2016Q216($0.50)($0.47)$44.82 million$41.40 millionViewListenView Earnings Details
11/4/2015Q116($0.42)($0.41)$43.90 million$43.90 millionViewN/AView Earnings Details
8/5/2015Q415($0.30)($0.27)$50.10 million$48.50 millionViewN/AView Earnings Details
4/29/2015Q315($0.33)($0.34)$46.84 million$47.00 millionViewListenView Earnings Details
1/28/2015Q215($0.34)($0.17)$43.97 million$44.70 millionViewListenView Earnings Details
10/29/2014Q115($0.33)($0.26)$40.24 million$41.40 millionViewListenView Earnings Details
8/6/2014Q214($0.28)($0.31)$37.21 million$39.56 millionViewListenView Earnings Details
4/30/2014Q114($0.32)($0.32)$34.15 million$34.90 millionViewListenView Earnings Details
1/29/2014Q2($0.34)($0.32)$30.62 million$32.30 millionViewListenView Earnings Details
10/30/2013Q1 2014($0.40)($0.29)$27.70 million$29.77 millionViewN/AView Earnings Details
8/7/2013Q4 2013($0.30)($0.28)$27.18 million$28.80 millionViewListenView Earnings Details
5/1/2013Q3 2013($0.33)($0.27)$25.70 million$26.47 millionViewN/AView Earnings Details
1/30/2013Q2 2013($0.31)($0.27)ViewN/AView Earnings Details
10/30/2012Q1 2013($0.34)($0.26)ViewN/AView Earnings Details
8/8/2012Q4 2012($0.26)($0.24)ViewN/AView Earnings Details
5/2/2012Q3 2012($0.25)($0.23)ViewN/AView Earnings Details
2/7/2012Q2 2012($0.20)($0.23)ViewN/AView Earnings Details
11/2/2011Q1 2012($0.24)($0.20)ViewN/AView Earnings Details
8/3/2011Q4 2011($0.07)($0.07)ViewN/AView Earnings Details
5/4/2011Q3 2011($0.14)($0.15)ViewN/AView Earnings Details
2/2/2011Q2 2011($0.19)($0.13)ViewN/AView Earnings Details
11/3/2010Q1 2011($0.35)($0.28)ViewN/AView Earnings Details
8/10/2010Q4 2010($0.40)($0.29)ViewN/AView Earnings Details
5/5/2010Q3 2010($0.47)($0.44)ViewN/AView Earnings Details
2/3/2010Q2 2010($0.49)($0.46)ViewN/AView Earnings Details
11/4/2009Q1 2010($0.43)($0.43)ViewN/AView Earnings Details
8/19/2009Q4 2009($0.58)($0.40)ViewN/AView Earnings Details
5/6/2009Q3 2009($0.88)$1.82ViewN/AView Earnings Details
8/5/2008Q4 2008($3.10)($6.93)ViewN/AView Earnings Details
5/7/2008Q3 2008($5.60)($3.32)ViewN/AView Earnings Details
2/26/2008Q2 2008($4.00)($6.32)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Cardiovascular Systems (NASDAQ:CSII) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Cardiovascular Systems (NASDAQ CSII) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 3.30%
Institutional Ownership Percentage: 82.56%
Insider Trading History for Cardiovascular Systems (NASDAQ:CSII)
Institutional Ownership by Quarter for Cardiovascular Systems (NASDAQ:CSII)

Cardiovascular Systems (NASDAQ CSII) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/31/2017Edward M BrownDirectorSell20,000$29.16$583,200.00View SEC Filing  
8/30/2017Edward M BrownDirectorSell13,031$29.09$379,071.79View SEC Filing  
8/17/2017Laura GillundInsiderSell2,350$30.42$71,487.0088,633View SEC Filing  
8/17/2017Scott R WardCEOSell5,529$30.41$168,136.89282,536View SEC Filing  
8/16/2017Alexander RosensteinGeneral CounselSell979$30.71$30,065.0952,296View SEC Filing  
8/16/2017Kevin J KennyCOOSell4,733$30.74$145,492.42153,339View SEC Filing  
8/16/2017Laurence L BetterleyCFOSell4,443$30.74$136,577.82223,557View SEC Filing  
5/17/2017Alexander RosensteinGeneral CounselSell219$32.30$7,073.7034,265View SEC Filing  
11/18/2016Alexander RosensteinGeneral CounselSell529$26.80$14,177.2034,484View SEC Filing  
11/18/2016Edward M BrownDirectorSell10,000$26.78$267,800.00View SEC Filing  
11/18/2016Laura GillundInsiderSell1,268$26.79$33,969.7269,541View SEC Filing  
11/15/2016Edward M BrownDirectorSell10,000$24.95$249,500.00View SEC Filing  
10/10/2016Paul A KoehnSVPSell30,910$25.07$774,913.70110,200View SEC Filing  
9/20/2016Camber Capital Management LlcMajor ShareholderSell1,100,000$23.26$25,586,000.00View SEC Filing  
9/7/2016Paul A KoehnSVPSell5,969$25.02$149,344.3873,321View SEC Filing  
8/22/2016Alexander RosensteinGeneral CounselSell234$23.82$5,573.8838,035View SEC Filing  
8/22/2016Kevin J KennyCOOSell3,166$23.95$75,825.70168,231View SEC Filing  
8/22/2016Laura GillundInsiderSell1,395$23.93$33,382.3582,817View SEC Filing  
8/22/2016Laurence L BetterleyCFOSell3,568$23.96$85,489.28253,031View SEC Filing  
8/22/2016Paul A KoehnSVPSell2,527$23.92$60,445.84100,125View SEC Filing  
8/17/2016Paul A KoehnSVPSell4,000$22.17$88,680.00102,652View SEC Filing  
2/26/2016Paul A KoehnSVPSell956$38.79$37,083.2473,266View SEC Filing  
2/23/2016Camber Capital Management LlcMajor ShareholderBuy250,000$7.55$1,887,500.00View SEC Filing  
1/25/2016Scott R WardCEOBuy2,700$9.30$25,110.009,533View SEC Filing  
10/2/2015Robert J. ThatcherinsiderSell64,700$16.31$1,055,257.00126,978View SEC Filing  
9/2/2015David MartinCEOSell19,646$23.81$467,771.26458,818View SEC Filing  
9/1/2015Kevin J KennyCOOSell5,289$23.85$126,142.65105,330View SEC Filing  
9/1/2015Laurence L BetterleyCFOSell9,597$23.96$229,944.12191,414View SEC Filing  
9/1/2015Paul A KoehnSVPSell4,946$23.86$118,011.5673,738View SEC Filing  
9/1/2015Robert J ThatcherInsiderSell5,282$23.85$125,975.70126,978View SEC Filing  
8/18/2015David MartinCEOSell17,688$23.99$424,335.12View SEC Filing  
8/18/2015Kevin J. KennyCOOSell3,913$24.00$93,912.00117,458View SEC Filing  
8/18/2015Laurence L BetterleyCFOSell8,476$24.00$203,424.00View SEC Filing  
8/18/2015Paul A. KoehnSVPSell4,402$23.99$105,603.9884,439View SEC Filing  
8/18/2015Robert J. ThatcherinsiderSell2,960$23.99$71,010.40138,243View SEC Filing  
8/12/2015Brent G BlackeyDirectorBuy2,500$22.74$56,850.00View SEC Filing  
5/28/2015Paul A KoehnSVPSell4,389$27.86$122,277.54View SEC Filing  
5/1/2015Brent G BlackeyDirectorBuy2,500$29.38$73,450.00View SEC Filing  
2/10/2015David MartinCEOSell7,500$35.85$268,875.00View SEC Filing  
2/5/2015David MartinCEOSell4,500$34.96$157,320.00View SEC Filing  
1/29/2015Kevin J KennyVPSell4,212$35.00$147,420.00View SEC Filing  
9/3/2014David MartinCEOSell10,248$28.85$295,654.80View SEC Filing  
9/3/2014Kevin J KennyVPSell3,528$28.85$101,782.80View SEC Filing  
9/3/2014Laurence L BetterleyCFOSell4,674$28.82$134,704.68View SEC Filing  
9/3/2014Paul A KoehnSVPSell2,612$28.85$75,356.20View SEC Filing  
9/3/2014Robert J ThatcherInsiderSell2,791$28.85$80,520.35View SEC Filing  
8/28/2014Paul A KoehnSVPSell1,315$28.82$37,898.30View SEC Filing  
8/22/2014David MartinCEOSell13,957$29.03$405,171.71View SEC Filing  
8/22/2014Kevin J KennyVPSell2,914$29.09$84,768.26View SEC Filing  
8/22/2014Laurence L BetterleyCFOSell6,578$29.02$190,893.56View SEC Filing  
8/22/2014Paul A KoehnSVPSell2,755$29.06$80,060.30View SEC Filing  
8/22/2014Robert J ThatcherInsiderSell3,225$29.06$93,718.50View SEC Filing  
8/19/2014David MartinCEOSell11,754$29.28$344,157.12View SEC Filing  
8/19/2014Kevin J KennyVPSell2,117$29.28$61,985.76View SEC Filing  
8/19/2014Laurence L BetterleyCFOSell5,725$29.28$167,628.00View SEC Filing  
8/19/2014Paul A KoehnSVPSell2,168$29.28$63,479.04View SEC Filing  
8/19/2014Robert J ThatcherInsiderSell2,537$29.28$74,283.36View SEC Filing  
7/16/2014David MartinCEOSell10,703$28.83$308,567.49View SEC Filing  
7/16/2014Kevin J KennyVPSell3,007$28.83$86,691.81View SEC Filing  
7/16/2014Laurence L BetterleyCFOSell3,984$28.83$114,858.72View SEC Filing  
7/16/2014Paul A KoehnSVPSell2,716$28.83$78,302.28View SEC Filing  
7/16/2014Robert J ThatcherInsiderSell2,939$28.83$84,731.37View SEC Filing  
4/25/2014Kevin KennyVPSell15,484$28.79$445,784.3666,841View SEC Filing  
2/24/2014David MartinCEOSell29,200$37.31$1,089,452.00354,052View SEC Filing  
2/20/2014Kevin KennyVPSell6,779$36.02$244,179.5882,325View SEC Filing  
1/30/2014David MartinCEOSell50,000$35.12$1,756,000.00354,052View SEC Filing  
1/30/2014Robert ThatcherVPSell35,139$35.06$1,231,973.3484,014View SEC Filing  
11/22/2013Robert ThatcherVPSell22,384$32.82$734,642.8884,014View SEC Filing  
10/31/2013James E FlahertyInsiderSell34,819$30.35$1,056,756.65View SEC Filing  
10/23/2013David MartinCEOSell154,080$27.73$4,272,638.40View SEC Filing  
10/23/2013James E FlahertyInsiderSell36,682$26.85$984,911.70View SEC Filing  
10/23/2013Robert J ThatcherVPSell23,426$28.19$660,378.94View SEC Filing  
10/22/2013Kevin J KennyVPSell5,608$27.31$153,154.48View SEC Filing  
10/16/2013Kevin J KennyVPSell4,182$22.95$95,976.90View SEC Filing  
10/14/2013David MartinCEOSell21,170$22.00$465,740.00354,052View SEC Filing  
9/20/2013David MartinCEOSell6,702$20.24$135,648.48354,052View SEC Filing  
9/20/2013James FlahertyInsiderSell2,066$20.28$41,898.48140,736View SEC Filing  
9/20/2013Robert ThatcherVPSell1,274$20.28$25,836.72130,105View SEC Filing  
9/19/2013Laurence BetterleyCFOSell2,694$20.32$54,742.08203,362View SEC Filing  
9/19/2013Paul KoehnSVPSell1,094$20.32$22,230.0859,074View SEC Filing  
9/18/2013David MartinCEOSell8,030$20.94$168,148.20360,754View SEC Filing  
9/18/2013James FlahertyInsiderSell2,970$20.94$62,191.80142,802View SEC Filing  
9/18/2013Laurence BetterleyCFOSell4,324$20.93$90,501.32206,056View SEC Filing  
9/18/2013Paul KoehnSVPSell1,732$20.93$36,250.7660,168View SEC Filing  
9/18/2013Robert ThatcherVPSell1,731$20.94$36,247.14131,379View SEC Filing  
9/10/2013John FriedmanDirectorSell48,273$20.73$1,000,699.298,000View SEC Filing  
8/30/2013David MartinCEOSell21,552$20.64$444,833.28297,649View SEC Filing  
8/30/2013James FlahertyInsiderSell7,165$20.64$147,885.60122,329View SEC Filing  
8/30/2013Kevin KennyVPSell1,899$20.64$39,195.3687,780View SEC Filing  
8/30/2013Laurence BetterleyCFOSell8,692$20.64$179,402.88177,554View SEC Filing  
8/27/2013David MartinCEOSell27,229$21.07$573,715.03319,201View SEC Filing  
8/27/2013James FlahertyInsiderSell9,051$21.07$190,704.57129,494View SEC Filing  
8/27/2013Kevin KennyVPSell2,396$21.07$50,483.7289,679View SEC Filing  
8/27/2013Laurence BetterleyCFOSell10,982$21.07$231,390.74186,246View SEC Filing  
8/16/2013James FlahertyInsiderSell1,255$20.51$25,740.05138,545View SEC Filing  
8/16/2013Laurence BetterleyCFOSell1,568$20.51$32,159.68197,228View SEC Filing  
8/14/2013James FlahertyInsiderSell4,902$21.31$104,461.62139,800View SEC Filing  
8/13/2013Kevin KennyVPSell2,529$21.20$53,614.8092,723View SEC Filing  
8/8/2013James FlahertyInsiderSell19,649$22.27$437,583.23120,282View SEC Filing  
7/30/2013David MartinCEOSell11,094$19.69$218,440.86View SEC Filing  
7/30/2013Laurence L BetterleyCFOSell6,579$19.72$129,737.88View SEC Filing  
7/30/2013Robert J ThatcherVPSell3,112$19.86$61,804.32View SEC Filing  
6/3/2013James E FlahertyInsiderSell10,000$21.00$210,000.00View SEC Filing  
5/31/2013Paul A KoehnVPSell2,472$20.00$49,440.00View SEC Filing  
5/28/2013Kevin J KennyVPSell4,182$19.95$83,430.90View SEC Filing  
5/20/2013Glen D NelsonDirectorBuy10,250$18.47$189,317.50View SEC Filing  
5/16/2013Glen D NelsonDirectorBuy4,753$18.93$89,974.29View SEC Filing  
5/13/2013Glen D NelsonDirectorBuy18,393$18.11$333,097.23View SEC Filing  
11/13/2012Glen D NelsonDirectorBuy33,000$11.96$394,680.00View SEC Filing  
8/23/2012David MartinCEOSell10,510$9.07$95,325.70View SEC Filing  
8/23/2012James E FlahertyInsiderSell4,018$9.07$36,443.26View SEC Filing  
8/23/2012Laurence L BetterleyCFOSell4,770$9.07$43,263.90View SEC Filing  
8/23/2012Paul A KoehnVPSell2,496$9.07$22,638.72View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Cardiovascular Systems (NASDAQ CSII) News Headlines

Source:
DateHeadline
Cardiovascular Systems (CSII) Stock Rating Lowered by ValuEngineCardiovascular Systems (CSII) Stock Rating Lowered by ValuEngine
www.americanbankingnews.com - April 17 at 11:07 AM
Cardiovascular Systems, Inc. (CSII) Receives Consensus Recommendation of "Hold" from BrokeragesCardiovascular Systems, Inc. (CSII) Receives Consensus Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - April 15 at 3:25 AM
Cardiovascular Systems (CSII) Lowered to "Sell" at BidaskClubCardiovascular Systems (CSII) Lowered to "Sell" at BidaskClub
www.americanbankingnews.com - April 14 at 6:22 PM
Cardiovascular Systems, Inc. to Webcast Fiscal 2018 Third-Quarter Earnings Conference Call Wednesday, May 2Cardiovascular Systems, Inc. to Webcast Fiscal 2018 Third-Quarter Earnings Conference Call Wednesday, May 2
finance.yahoo.com - April 11 at 4:38 PM
Cardiovascular Systems (CSII) Rating Increased to Hold at BidaskClubCardiovascular Systems (CSII) Rating Increased to Hold at BidaskClub
www.americanbankingnews.com - April 9 at 6:03 AM
Cardiovascular Systems, Inc. (CSII) Expected to Post Quarterly Sales of $55.63 MillionCardiovascular Systems, Inc. (CSII) Expected to Post Quarterly Sales of $55.63 Million
www.americanbankingnews.com - April 7 at 2:47 AM
-$0.02 Earnings Per Share Expected for Cardiovascular Systems, Inc. (CSII) This Quarter-$0.02 Earnings Per Share Expected for Cardiovascular Systems, Inc. (CSII) This Quarter
www.americanbankingnews.com - April 5 at 3:18 PM
Cardiovascular Systems (CSII) Stock Rating Lowered by BidaskClubCardiovascular Systems (CSII) Stock Rating Lowered by BidaskClub
www.americanbankingnews.com - April 3 at 11:00 AM
Cardiovascular Systems (CSII) Rating Increased to Sell at BidaskClubCardiovascular Systems (CSII) Rating Increased to Sell at BidaskClub
www.americanbankingnews.com - March 30 at 6:14 PM
Cardiovascular Systems (CSII) Lowered to "Strong Sell" at BidaskClubCardiovascular Systems (CSII) Lowered to "Strong Sell" at BidaskClub
www.americanbankingnews.com - March 29 at 6:54 PM
Cardiovascular Systems (CSII) Upgraded to Sell by BidaskClubCardiovascular Systems (CSII) Upgraded to Sell by BidaskClub
www.americanbankingnews.com - March 27 at 4:00 PM
Cardiovascular Systems (CSII) Downgraded by ValuEngineCardiovascular Systems (CSII) Downgraded by ValuEngine
www.americanbankingnews.com - March 25 at 7:32 PM
Cardiovascular Systems (CSII) vs. Owens & Minor (OMI) Head to Head ComparisonCardiovascular Systems (CSII) vs. Owens & Minor (OMI) Head to Head Comparison
www.americanbankingnews.com - March 25 at 3:22 PM
Cardiovascular Systems, Inc. (CSII) Given Average Rating of "Hold" by AnalystsCardiovascular Systems, Inc. (CSII) Given Average Rating of "Hold" by Analysts
www.americanbankingnews.com - March 21 at 3:28 AM
Zacks: Analysts Expect Cardiovascular Systems, Inc. (CSII) to Post -$0.02 Earnings Per ShareZacks: Analysts Expect Cardiovascular Systems, Inc. (CSII) to Post -$0.02 Earnings Per Share
www.americanbankingnews.com - March 19 at 3:14 PM
Cardiovascular Systems (CSII) and Invacare (IVC) Critical ComparisonCardiovascular Systems (CSII) and Invacare (IVC) Critical Comparison
www.americanbankingnews.com - March 16 at 12:31 PM
Cardiovascular Systems (CSII) Presents At Barclays Global Healthcare Conference 2018 - SlideshowCardiovascular Systems (CSII) Presents At Barclays Global Healthcare Conference 2018 - Slideshow
seekingalpha.com - March 14 at 10:12 AM
Cardiovascular Systems Inc (CSII) Sees Large Increase in Short InterestCardiovascular Systems Inc (CSII) Sees Large Increase in Short Interest
www.americanbankingnews.com - March 13 at 1:53 AM
BidaskClub Upgrades Cardiovascular Systems (CSII) to "Buy"BidaskClub Upgrades Cardiovascular Systems (CSII) to "Buy"
www.americanbankingnews.com - March 10 at 6:34 PM
Cardiovascular Systems (CSII) Up 2% Since Earnings Report: Can It Continue?Cardiovascular Systems (CSII) Up 2% Since Earnings Report: Can It Continue?
finance.yahoo.com - March 9 at 5:41 PM
Cardiovascular Systems Presents LIBERTY 360° 18-Month Outcomes at CRT18 Interventional Cardiology ConferenceCardiovascular Systems Presents LIBERTY 360° 18-Month Outcomes at CRT18 Interventional Cardiology Conference
finance.yahoo.com - March 6 at 4:57 PM
Cardiovascular Systems Inc (CSII) Expected to Post Quarterly Sales of $55.63 MillionCardiovascular Systems Inc (CSII) Expected to Post Quarterly Sales of $55.63 Million
www.americanbankingnews.com - March 4 at 4:50 AM
-$0.02 Earnings Per Share Expected for Cardiovascular Systems Inc (CSII) This Quarter-$0.02 Earnings Per Share Expected for Cardiovascular Systems Inc (CSII) This Quarter
www.americanbankingnews.com - March 2 at 7:12 PM
Champlain Investment Partners LLC Purchases 396,145 Shares of Cardiovascular Systems Inc (CSII)Champlain Investment Partners LLC Purchases 396,145 Shares of Cardiovascular Systems Inc (CSII)
www.americanbankingnews.com - February 27 at 5:40 AM
Cortina Asset Management LLC Sells 98,118 Shares of Cardiovascular Systems Inc (CSII)Cortina Asset Management LLC Sells 98,118 Shares of Cardiovascular Systems Inc (CSII)
www.americanbankingnews.com - February 26 at 3:04 PM
Cardiovascular Systems Inc (CSII) Receives Consensus Rating of "Hold" from AnalystsCardiovascular Systems Inc (CSII) Receives Consensus Rating of "Hold" from Analysts
www.americanbankingnews.com - February 24 at 3:40 AM
Cardiovascular Systems (CSII) Presents At Leerink Partners 7th Annual Global Healthcare Conference - SlideshowCardiovascular Systems (CSII) Presents At Leerink Partners 7th Annual Global Healthcare Conference - Slideshow
seekingalpha.com - February 15 at 4:43 PM
Cardiovascular Systems, Inc. Announces First Patients Treated from Radial Access Using Its Diamondback 360® Extended Length Peripheral Orbital Atherectomy DeviceCardiovascular Systems, Inc. Announces First Patients Treated from Radial Access Using Its Diamondback 360® Extended Length Peripheral Orbital Atherectomy Device
finance.yahoo.com - February 14 at 9:17 AM
-$0.02 EPS Expected for Cardiovascular Systems Inc (CSII) This Quarter-$0.02 EPS Expected for Cardiovascular Systems Inc (CSII) This Quarter
www.americanbankingnews.com - February 13 at 7:14 PM
Cardiovascular Systems (CSII) Cut to Hold at Zacks Investment ResearchCardiovascular Systems (CSII) Cut to Hold at Zacks Investment Research
www.americanbankingnews.com - February 12 at 4:52 PM
Equities Analysts Set Expectations for Cardiovascular Systems Incs Q3 2018 Earnings (CSII)Equities Analysts Set Expectations for Cardiovascular Systems Inc's Q3 2018 Earnings (CSII)
www.americanbankingnews.com - February 12 at 4:44 AM
Cardiovascular Systems Inc to Post Q3 2018 Earnings of ($0.01) Per Share, Northcoast Research Forecasts (CSII)Cardiovascular Systems Inc to Post Q3 2018 Earnings of ($0.01) Per Share, Northcoast Research Forecasts (CSII)
www.americanbankingnews.com - February 12 at 4:44 AM
Q3 2018 EPS Estimates for Cardiovascular Systems Inc (CSII) Cut by Leerink SwannQ3 2018 EPS Estimates for Cardiovascular Systems Inc (CSII) Cut by Leerink Swann
www.americanbankingnews.com - February 12 at 4:44 AM
Cardiovascular Systems (CSII) Lifted to "Buy" at Zacks Investment ResearchCardiovascular Systems (CSII) Lifted to "Buy" at Zacks Investment Research
www.americanbankingnews.com - February 9 at 9:30 PM
Brokers Set Expectations for Cardiovascular Systems Incs Q4 2019 Earnings (CSII)Brokers Set Expectations for Cardiovascular Systems Inc's Q4 2019 Earnings (CSII)
www.americanbankingnews.com - February 9 at 5:50 PM
Q4 2018 Earnings Forecast for Cardiovascular Systems Inc Issued By Leerink Swann (CSII)Q4 2018 Earnings Forecast for Cardiovascular Systems Inc Issued By Leerink Swann (CSII)
www.americanbankingnews.com - February 9 at 3:52 PM
Cardiovascular Systems (CSII) Price Target Lowered to $30.00 at Leerink SwannCardiovascular Systems (CSII) Price Target Lowered to $30.00 at Leerink Swann
www.americanbankingnews.com - February 8 at 1:30 PM
Cardiovascular Systems (CSII) Announces Quarterly  Earnings ResultsCardiovascular Systems (CSII) Announces Quarterly Earnings Results
www.americanbankingnews.com - February 8 at 9:56 AM
Where Cardiovascular Systems Inc (NASDAQ:CSII) Stands In Terms Of Earnings Growth Against Its IndustryWhere Cardiovascular Systems Inc (NASDAQ:CSII) Stands In Terms Of Earnings Growth Against Its Industry
finance.yahoo.com - February 8 at 8:48 AM
Cardiovascular Systems, Inc. Reports Fiscal 2018 Second-Quarter Financial ResultsCardiovascular Systems, Inc. Reports Fiscal 2018 Second-Quarter Financial Results
finance.yahoo.com - February 8 at 8:48 AM
Cardiovascular Systems reports 2Q lossCardiovascular Systems reports 2Q loss
finance.yahoo.com - February 8 at 8:48 AM
Cardiovascular Systems, Inc. Appoints Jeff Points as Chief Financial OfficerCardiovascular Systems, Inc. Appoints Jeff Points as Chief Financial Officer
finance.yahoo.com - February 8 at 8:48 AM
Cardiovascular Systems (CSII) Updates Q3 Earnings GuidanceCardiovascular Systems (CSII) Updates Q3 Earnings Guidance
www.americanbankingnews.com - February 8 at 12:12 AM
Cardiovascular Systems Micro Crown Now Available in JapanCardiovascular Systems' Micro Crown Now Available in Japan
www.zacks.com - February 6 at 9:15 AM
Cardiovascular Systems' Micro Crown Now Available in JapanCardiovascular Systems' Micro Crown Now Available in Japan
finance.yahoo.com - February 5 at 4:16 PM
Cardiovascular Systems (CSII) Cut to Sell at BidaskClubCardiovascular Systems (CSII) Cut to Sell at BidaskClub
www.americanbankingnews.com - February 3 at 8:46 PM
Financial Survey: Cryolife (CRY) & Cardiovascular Systems (CSII)Financial Survey: Cryolife (CRY) & Cardiovascular Systems (CSII)
www.americanbankingnews.com - February 3 at 7:20 PM
Cardiovascular Systems, Inc. Announces Commercial Launch in JapanCardiovascular Systems, Inc. Announces Commercial Launch in Japan
finance.yahoo.com - February 1 at 4:18 PM
Cardiovascular Systems (CSII) Scheduled to Post Earnings on WednesdayCardiovascular Systems (CSII) Scheduled to Post Earnings on Wednesday
www.americanbankingnews.com - January 31 at 3:38 AM
Cardiovascular Systems Inc (CSII) Given Consensus Recommendation of "Hold" by AnalystsCardiovascular Systems Inc (CSII) Given Consensus Recommendation of "Hold" by Analysts
www.americanbankingnews.com - January 30 at 3:28 AM

SEC Filings

Cardiovascular Systems (NASDAQ:CSII) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Cardiovascular Systems (NASDAQ:CSII) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Cardiovascular Systems (NASDAQ CSII) Stock Chart for Saturday, April, 21, 2018

Loading chart…

This page was last updated on 4/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.